.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Wibke S. Ballhorn

Frankfurt am Main / DE

Universitätsklinikum Frankfurt

Weitere Beteiligungen

Mo, 03.06.2024
Poster Presentation
P-MP-001
Inhibition of bacterial adherence to fibronectin as a novel therapeutic concept
Microbial Pathogenicity
Mo, 03.06.2024
Poster Presentation
P-MP-009
Role of multi-drug-resistance Gram negative bacteria in the development of acute- on-chronic liver failure (ACLF).
Microbial Pathogenicity
Mo, 03.06.2024
Poster Presentation
P-MP-033
Inhibition of Bartonella bacilliformis hemolysis as a novel anti-virulence strategy against Oroya fever
Microbial Pathogenicity
Mi, 05.06.2024
12:00 – 12:15 12 Min. 3 Min.
Oral Presentation
OP-NRC-005
Identification of hemolysis-related pathogenicity factors of Bartonella bacilliformis
National Reference Centers and Consiliary Laboratories